ABSTRACf. The transfer and metabolism of retinol by human placenta was investigated using an in vitro perfusion system with independent maternal and fetal circulations. 3H-retinol bound to albumin added to the maternal perfusate was rapidly taken up and concentrated by the placenta to levels 16.5 ± 5.28 times the maternal perfusate. Approximately 8% of the retinol retained in the placenta was esterified. No metabolites were detected in the perfusates. Perfusion of placenta with retinol bound to retinol-binding protein (RBP) reduced the placental concentration to 4.4 ± 1.72 times the maternal concentration and eliminated evidence of metabolism. The transfer rate of RBP: 3H-retinol was less than that of albumin.'r'Ccretinol when measured concurrently in three experiments (clearances 0.11 versus 0.75 mL/min, 0.21 versus 1.7 mL/min, and 0.29 versus 0.48 mL/min, respectively). Transfer of the radioactive retinol was more rapid than 125I_RBP or albumin, indicating that retinol was transferred independently of the proteins. The transfer index of retinol (clearance retinol:clearance L-glucose) was 0.73 ± 0.085 compared to 2.1 ± 0.36 for thiamin and 3.4 ± 0.95 for riboflavin, both water-soluble vitamins with active transport systems. The retinol transferred to the fetal perfusate is not bound to RBP, as demonstrated by gel filtration chromatography and chromatography on a transthyretin affinity column, despite the availability of RBP in the cord serum added to the perfusate. The endogenous retinol in the cord serum is bound to RBP. The conclusions derived are that RBP binding reduces the accumulation of retinol in the placenta and the transfer to the fetus, that retinol is transferred intact to the fetal circulation where immediate binding is not to RBP, and that redistribution to RBP occurs subsequently, possibly in fetal liver. (Pediatr Res 32: 195-199, 1992) 
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The importance of vitamin A to the developing mammalian fetus has been amply demonstrated in the experimental animal. Both deficiencies and excesses are teratogenic (1, 2). The pertinence of these observations to the human has recently become tragically evident. Retinoic acid administered to the pregnant female for the treatment of acne has caused severe congenital abnormalities in the newborn infant (3) .
Despite its obvious importance, little is known about the placental transfer of retinoids. The question has been approached in the sheep (4) and monkey (5), but the placental role is difficult to deduce from studies in the intact animal and extrapolation of results to the human is uncertain. Measurements have been made in the human of maternal and cord retinol levels (6) that are interesting but shed little light on placental functions. Torma and Vahlquist (7) have studied the uptake of vitamin A and RBP by fragments of human placenta in vitro and speculated concerning the transplacental process. The model, however, does not permit differentiation of events at the maternal surface of the placenta from those at the fetal surface.
In the present study, we have used the technique of in vitro perfusion of a human placental lobule. By establishing independent "maternal" and "fetal" circulations, it was possible to study the transplacental transfer of retinol, the principal circulating form of vitamin A. In vitro, retinol circulates bound to a specific serum protein, RBP, which in turn complexes with TTR (8, 9) . We have investigated the placental transfer and metabolism of retinol bound to RBP and compared the results to retinol bound nonspecifically to serum albumin. The comparison has provided insights into the physiologic role of RBP and the biochemical mechanism through which retinol is taken up by the tissues.
MATERIALS AND METHODS
Perfusion technique. Term placentas of clinically normal pregnancies were obtained after delivery by cesarean section or by vagina. Independent maternal and fetal circulations were established to a placental lobule as previously described (10) . Flow rates approximated 12-15 mL/min on the maternal side and 4-6 mL/min on the fetal side. In the "closed" experiments, the perfusate was recirculated through a 70-mL reservoir. The perfusions were performed under reduced lighting, as were all procedures with retinol, because of its light sensitivity.
Perfusate. The basic perfusate consisted of Earle's buffered salt solution equilibrated against Oz-COz, 95-5%, pH 7.4, with 150 mg/dl. of n-glucose and mixed amino acids in physiologic concentration. In the experiments with albumin-bound retinol, 10 g/L BSA was added to the perfusate with 3H-retinol -20000 cpm/ml, and retinol 1.7 JLmol/L. Ten g/L albumin in the perfusate solubi1izes the retinol and provides sufficient binding to prevent absorption to the perfusion tubing and apparatus similar to previous experience with vitamin D (11). Binding was accomplished by incubating 3H-retinol with BSA for 1 h. For the RBP experiments, 3H-retinol was bound to RBP by incubation 196 DANCIS E T AL.
at 3rC .for 1 h or at 5°C overnight, while rotating gently. The RBP :retmol was added to perfusate containing 20 % maternal serum.
Preparation of samples fo r analysis. Perfusate samples were add ed directl y to scintillant to determine radioactivity. If there was an insufficient concentration of counts for chromatographic an alysis, samples were first concentrated with an Amicon -BI5 concentrator (Amicon Corp., Beverly, MA) for gel filtration analysis or by extraction with hexane for reverse phase chro matography. Th.roughout the analytical procedures, retinol was protected against oxidation by the addition ofbutylated hydroxytoluene, 6.1 mM (1 mg/ml.), or a -tocopherol, 100 JLg.
At the end of the perfusion, 2-4 g of villous tissue was dissected from the perfused placenta and homogenized in 10 volumes of methanol:hexane (1:9). The extraction was repeated and both extracts combined and evaporated under vacuum. The residue was dissolved in 3 mL hexane containing 6.1 mM butylated hydroxytoluene, transferred to a small tube, and taken to dryness . The residue was dissolved in 0.5-1 .0 mL of meth anol and passed through a 0.22-JLm filter, and 100 to 500 JLL were analyzed by HPLC. Chromatographic analysis. Reverse phase HPLC was used to identify retinoic acid, retinol , and the retin yl esters. Separation was on a Waters RPC-I8 column (Waters Associates Milford MA) with a UV detector at 325 nm . The mobile phas~was 80% acetonitrile in 1% ammonium acetate with a flow rate of 1 mLI min. Retinol and retinoic acid, 100 JLg, were added to the sample be,fore injection to serve as standards, the former eluti ng at 7 nun and the latter at 4.5 min . For the retin yl esters, 100% methanol was the mobil e phase , retin yl palmitate was the standard, and elution time was 13.4 min (12) .
High performance gel filtration was performed to separatẽ aterials according to molecular size (13) . Samples were injected into a Waters TSK 2000 SW column equipped with a UV or fluorescence detector. The mobile phase was 0.1 M monobasic potassium phosphate titrated to pH 7.4 and 0.05% sodium azide. Elution times were 14.4 min for albumin and 20.1 min for RBP.
A TTR-sepharose affinity column was used to identify RBPbound retinol. The column was equilibrated at room tempe rature in 50 mM tris-chloride, 150 mM NaCl, and 0.05% NaN 3 at pH 7.4. Samples were applied and recycled through a 2-mL reservoir for 2 h at room temperature. The column was washed with 22 mL of buffer to remove materials not bound to the column and then the bound RBP was eluted with 30 mL H 2 0 at pH 8.0. Under these conditions, approximately 50% of the RBP in the sample equilibrated with and was retained by the column.
Normal phase chroma tography was carried out on two Waters 5 JLm Resolve Silica colum ns linked in series and eluted with 0.4 % dieth yl ether in hexane flowing at 1.2 ml.zrnin, using a previo usly described procedure for the separation of th e geometric isomers of retinol (14) .
Clearances. Clearance (mL/min) was calculated as previously described (10) .
Materials. Perfusates were prep ared by GIBCO (Gra nd Island , NY ) according to specifications. Retinol [I I, 12(n)FH-vitamin A alcohol , 60 Ci/umol; inulin-r 'Ocarbox ylic acid 9 mCi/"mol'
an L-I-C-glucose, 40-60 mCi/JLmol, were purchased from Amersham (Arlington Heights, IL). Th e retinoids were obtai ned from Sigma Chemical Co. (St. Louis , MO) and the HPLC solvents from Fisher Scientific Co. (Pittsburgh, PA). If indicated, th e 3H-retinol was further purified by reverse-phase chromatography with a -tocopherol as antioxidant. RBP was purified to homogeneity from human serum by conventional chromatography as previously described ( 15) . Human 125I_RBP was prepared by the lactoperoxidase method according to standard procedures (16) . The TTR:sepharose affinity column was prepared by cross-linking 10 mg of purifi ed TTR (15) to 5 mL of CNBr-activated sepharose 4B (LKB-Pharm acia Biochete chnology Inc., Piscataway , NJ) following the instructions provided by the manufacturer.
RESULTS

Transf er and M etabolism ofAlbumi n-Bound R etinol. 3H-reti-
nol was incubated with serum albumin at 3rC for 1 h which ermitted protei~-binding as demonstrated by TCA p;ecipitation. The albumin-bound retinol was added to the maternal perfusate, which contained 10 g/L serum albumin and recirculated for th~duration of the perfusion. Th e fetal pe;fusate, which also~ontamed IO .g/L serum albumin, was kept open (two expenments) or recircu lated (four experiments).
Placental uptake . Uptake of 3H-retinol from the maternal perfusate was very rapid during the first 20 min and continued at a slower rate throughout the perfusion. At the end of the perfusion , the con centrations of 3H-retinol in the placenta and m the maternal perfusate were measured. The concentration in the placenta was 16.5 ± 5.28 times that in the perfusate (Table  1) .
In five experiments, the albumin-bound 3H-retinol was added to the fetal perfusate that was recirculated. The ratio of the concentrations of 3H-retinol in the placenta to the fetal perfusate was 16.0 ± 4.79, suggesting that similar mechanisms were involved in uptake and concentration of retinol from the mat ernal and fetal perfusate.
M etabolism. The maternal and fetal perfusates were analyzed by reverse phase HPLC. No radioacti ve metabolites were detected. In four experiments, the placenta was extracted at the completion of the perfusion and also analyzed. Over 90% of the radioactivity coeluted with retinol ; 8, 4, 7, and 11% eluted with retin yl esters. Retinoic acid was not detected .
Placental transf er. Transplacental clearances of 3H-retinol were calculated (Table 2 ). 14C-inulin was included in these experiments to pro vide a simultaneous m~asure of diffusion of a large (5-kD), water-soluble molecule. Retinol was transferred IO-fold more rapi dly than inul in (10.2 ± 2.58). Albumin, to which the retinol was bound, is larger than inulin (60 kD), with a permeability constant across the perfused placenta of 1.5 x 10-3 cm 3/min/g as compared to 6.0 x 10-3 cm 3 /min/g for inulin (17) . It is evident that retinol had to be released from albumin before or during transport to permit its more rapid transfer.
Transfer and M etabolism of RBP-Bound R etinol. Transf er of RBP. Retinol circulates in maternal and fetal serum bound to RBP. The possibility th at retinol was transfe rred to the fetus as RBP:retinol was initially addressed. RBP:retinol was iodinated with 125 1 and added to the maternal perfusate with 14C-inulin. The mat ernal and fetal perfusates were recirculated for 120 min in two experiments. The maternal RBP remained over 90% TCA precipitable. Within the placenta, 55% of the 125 1 was no longer TCA precipitable. It was evident that the placenta rapidly degraded the RBP and released the degradation products into the fetal circulation.
The rate of transfer of TCA-precipitable 125 1was 0.33 and 0.44 that of inulin in the two experiments. The extensive degradation ofRBP durin g transfer across the placenta and the relatively slow rate of transfer made it very unlikely that retinol bound to RBP was transferred intact to the fetus. That possibility was further eliminated by later experiments described below.
Uptake of RBP. In the next series of experiments, 3H-retinol was incubated with purified RBP at 37°C for I h. The RBP: 3H-retinol was added to the maternal perfusate to which had been added maternal serum to a concentration of 20%. Binding of 3H-retinol to RBP was confirmed by reverse-phase chromatography of the maternal perfusate before perfusion and after 40 min of perfusion. The fetal perfusate contained 20% cord serum. The maternal perfusate was recirculated. The fetal perfusate was recirculated in three experiments and kept open in two.
At the completion of the perfusion, the concentration of 3H_ retinol in the placenta was much lower than in the experiments with albumin:retinol (Table I) .
Me tabolism. No evidence of metabolism of the 3H-retinol was detected by reverse phase chromatography in the maternal and fetal perfusates or in placenta extracts. The retinyl esters observed with the high concentrations of retinol in the placenta after perfusion with albumin:retinol were not evident.
Placental transfer. The effect of RBP binding on the placental transfer of retinol was investigated by adding both RBP: 3H-retinol and albuminr'Oretinol to the maternal perfusate. Clearances of the two preparations were simultaneously measured in three experiments. RBP binding reduced the clearance of retinol as compared to albumin :retinol (0.11 versus 0.75 mL/min, 0.21 versus 1.7 mL/min, and 0.29 versus 0.48 mL/min).
It was interesting to compare the placental tran sfer rate of retinol to those of other nutrients studied with the same techniqu e, particularly the water-soluble vitamin s. For this information , RBp: 3H -retinol and 14C-L-glucose were added to the maternal perfusate and the placental clearances simultaneously measured. L-Glucose is a water-soluble molecule tran sferred by membrane-limited simple diffusion. By using the ratio of the clearances of riboflavin to L-glucose, interexperimental variation is reduced and comparison of substrates becomes more meaningful. The ratio of retinol to L-glucose clearance, or transfer index, in five experiments was 0.73 ± 0.085 (Table 3 vitamins previously studied in this laboratory, were 2.1 ± 0.36 and 3.4 ± 0.95, respectively (18, 19) .
Protein-binding of transferred 3H-retinol. RBp: 3H-r etinol was added to maternal perfusate containing 20% maternal serum and recirculated for 60 min. The fetal perfusate containing 20% cord serum was not recirculated. After 40 min, an aliquot of maternal perfusate was drawn from the reservoir and the fetal perfusate was collected. Both were analyzed by gel filtration on HPLC ( fig. I ).
With the matern al perfusate, a radioactive peak eluted at 21 min , consistent with RBP:retinol. In contrast, the radioactivity in the fetal perfusate eluted as a peak after 15 min, consistent with molecules of 60 kD and above.
The identity of the protein that binds the retinol was further pursued using a TTR affinity column that selectively binds to RBP. Under the conditions of analysis, approximately 50% of prepared RBp: 3H-retinol is retained by the column. The maternal perfusate to which RBp: 3H-r etinol had been added performed as would be expected (Table 4 ). The 3Hc!etinol in the fetal perfusate was not retained by the column, 'confirming that the transferred 3H-retinol was not bound to RBP.
The binding of the endogenous nonradioactiv e retinol contained in the sera added to the matemal and fetal perfusates was also investigated using the characteristic fluorescence of RBP:retinoi. Retention by the affinitycol umn was slightly higher than that of the laboratory-prepared RBP:retinol and was the Table 4 . TTR column assay fo r RBP binding ofretinol in maternal andfetal perfusate" * RBp : 3H -retinol was added to the maternal per fusate containing 20% maternal seru m and tran sfer into fetal perfusate with 20% cord serum was investigated. The affinity column retained about half the radioactivity in the maternal perfusate, similar to the results obta ined with laboratory-prepared RBP:retinol. Non e of the transferred 3H-retinol was retained by the column. The endogenous retinol in th e mat erna l and cord sera added to the perfusates was retained equally and at a slightly h igher level than the laboratory-prepared maternal perfusate.
Retinol is poorly soluble in water. Several carri er proteins have evolved for transporting retinol through aqueous environments, In the circulation, retinol is transported bound to a specific plasma protein, RBP (8) . Cell surface receptors for RBP have been reported on the brush border of human placenta (20) . The experiments with albumin-bound retinol demonstrat~, however, that neither specific protein binding nor receptor-mediated transport are required for delivery of retinol to the placenta or the fetus.
The mechanisms involved in transport of albumin:retinol appear to be the same for other lipophilic materials when bound to albumin, as suggested by studies of the FFt\ and of estrogens  (2 1, 22) . The ligands are released from the protem to the placenta, bound to placental proteins, and then released to fetal albumin. Uptake and concentration of the ligand in the placenta a~e consistent with the relati ve association constants for albumm and placental proteins. The observations on transport can be explained physicochemically, but more complex biologic processes are not excluded. Under physiologic conditions, retinol is delivered to the placenta bound to RBP. The first steps in transport of retinol to the fetus require release from RBP and uptake into the placenta. Noy and Blaner (23) have proposed a model for the c~llul~r uptake of retinol that can be applied to the placenta. Retmol IS progressively released from RBP in the circulation as it enters into equilibrium with the plasma membrane, where it moves from the outer leaflet to the inner leaflet of the membrane (24, 25) . Ret inol then interacts with cytoplasmic proteins. As with the albumin-bound hydrophobic materials, the concentration of retinol within the cell is determined by th e relative binding affinities and available binding sites of the transport protein delivering the retinol and the intracellular binding proteins. Receptor-mediated transport (20) is not a feature of the model proposed by Noy and Blaner.
Placental uptake and transfer of 3H-retinol is reduced when 3H-retinol is bound to RBP as compared to albumin-bound retinol, consistent with the higher avidity of RB.P for retinol and suggesting that the primary function of RBP IS to control the delivery of retinol to tissues. RBP binding pre vents excessive accumulation of a potentially harmful material. Vitamin D binding protein may have a similar function. The placental transfer of 25-hydro xycholecalciferol is sharply reduced when 25-hydroxycholecalciferol is bound to its specific t~ansport protein as compared to transfer when bound to albumm ( 11). .
There is no information concerning the route and mechamsms by which retinol traverses the placenta to reach the fetal circulation. The parallels between placental uptake of retinol and that of FFA suggest that similarities may exist in intracellular transport. A superfamily of stru cturally related intracellular proteins capable of binding lipophilic materials has been described (26) . The members of this family include the fatty acid-binding proteins cellular retinol-binding protein type I, cellular retinolbinding protein type II, cellular retinoic acid-binding protei?, myelin P2, and adipocyte P2 (27) . The pro teins ar~located m the cytoplas m and are th ought to play a rol~in the mtrace~lul~r transport and metabolism of their respective hydro~hobl~It-gands . The fatty acid-binding proteins that have been identified in human placenta appear to be unique isoforms , based on serologic evidence (28) . At present, only limited information is available regarding the presenc e of retinoid-binding proteins in the human placenta. Cellular retinol-binding protein type I mRNA could not be detected by Northern blot analysis in total RNA from hu man placenta (29) , but data concerning the possible presence of other retinoid-binding proteins in the placenta are not available .
The present studies have shown that retinol is transferred into the fetal circulation unchanged by placental metabolism and that the transferred retino l is not bound to RBP. On chromatography (Fig. 1) , the transferred 3H-retinol is bound to protein(s) of 60 kD or greater. It is possible that the retinol is secreted bound to a placental pro tein. Th e placental synt hesis of apolipoproteinc ou ld pro vide such an opportunity (30) . Alternatively, the retinol, on release from the placenta, binds im mediately to available lipid carrier prot eins such as albumin. or lipoproteins. The fe~al proteins, fetuin (3 1) and o-fetoprotein (32) , are also potential lipid carriers. This binding is transient, with subsequent transfer to RBP ( 198 same in the maternal and fetal perfusates (Tab le 4), indicating that the endogenous retinol was bound to RBP in maternal and cord blood . The difference in binding to the TTR-affinity column between the laboratory-prepared RBP:retinol and that circulating in serum (Tab le 4) may be explained by the method used for the laboratory preparation. Trace 3H-retinol was .incu!Jated with purified RBP, permitting bin.ding to uno~cupled~Ites on . the protein and/or interchange WIth bound retmol. ThIS techmque was gentler than remo ving bound retinol with organic solvents and replacing it with 3H-retinol. Binding of 3H-r~tinol~as. demonstrated by TCA precipitation and gel filtration, Binding of tracer, however, may not have been identical to the endogenous retinol.
On reverse phase chromatography, the transferred radioactivity eluted with authentic retinol. The possibility remained~hat th e transferred retinol had been subtly altered by metabolism, sufficient to interfere with RBP binding but not detectable by reverse phase chromatography. Normal phase chromatography provides greater resolut ion of the isomers of retino~an~.its metabolites. In two experiments, the transferred radioactivity eluted with authentic retino l. Direct evidence tha t the transferred 3H-retinol retaine d its capacity for RBP binding was obtained by extracting the transferred radioactivity from the fetal perfusate with hexane and incubating the extract with purified RBP at 3rC for 1 h. There was complete binding of the extracted radioactivity. Therefore, the transferred 3H-retinol was unaltered and retained its potential for binding to RBP but had not bound to RBP even tho ugh the protein was present in the perfusate.
The possibility remained that the RBP circulating in fetal plasma was unable to accept the placentally transferred 3H_ retinol because it was fully saturated. This was addressed by incubating cord serum with 3H-retinol. Reverse phase chromatograph y and TTR-affinity chromatography indicated that the 3H-retinol was bound to RBP.
